Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Melibiase family protein | 0.0071 | 0.128 | 0.2847 |
Trypanosoma brucei | mitochondrial DNA polymerase beta-PAK | 0.0149 | 0.4061 | 0.3871 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0059 | 0.083 | 0.138 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0107 | 0.2557 | 0.6794 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0098 | 0.2245 | 1 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0098 | 0.2245 | 0.5967 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0059 | 0.083 | 0.1423 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0054 | 0.0657 | 0.0358 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.059 | 0.2628 |
Mycobacterium ulcerans | hypothetical protein | 0.0166 | 0.4664 | 1 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0107 | 0.2557 | 0.6794 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0314 | 1 | 1 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0098 | 0.2245 | 0.4707 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0149 | 0.4061 | 0.3871 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0052 | 0.059 | 0.1312 |
Echinococcus multilocularis | Alpha N acetylgalactosaminidase | 0.0107 | 0.2557 | 0.5439 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0059 | 0.083 | 0.2206 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0071 | 0.128 | 0.3402 |
Mycobacterium tuberculosis | Probable epoxide hydrolase EphA (epoxide hydratase) (arene-oxide hydratase) | 0.0158 | 0.4391 | 0.9289 |
Echinococcus granulosus | Alpha N acetylgalactosaminidase | 0.0107 | 0.2557 | 0.5439 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.0314 | 1 | 1 |
Toxoplasma gondii | melibiase subfamily protein | 0.0107 | 0.2557 | 1 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0161 | 0.4497 | 1 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0107 | 0.2557 | 0.6794 |
Echinococcus multilocularis | Glycoside hydrolase, family 27 | 0.0107 | 0.2557 | 0.5439 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0314 | 1 | 1 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0071 | 0.128 | 0.3402 |
Brugia malayi | jmjC domain containing protein | 0.0161 | 0.4497 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0059 | 0.083 | 0.2206 |
Mycobacterium ulcerans | epoxide hydrolase EphA | 0.0158 | 0.4391 | 0.9289 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0052 | 0.059 | 0.1312 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0098 | 0.2245 | 0.5967 |
Loa Loa (eye worm) | hypothetical protein | 0.0071 | 0.128 | 0.5702 |
Brugia malayi | jmjC domain containing protein | 0.0098 | 0.2245 | 0.4993 |
Leishmania major | mitochondrial DNA polymerase beta-PAK, putative | 0.0149 | 0.4061 | 0.3524 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0098 | 0.2245 | 0.4707 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0166 | 0.4664 | 1 |
Schistosoma mansoni | jumonji domain containing protein | 0.014 | 0.3763 | 1 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0107 | 0.2557 | 0.6794 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0063 | 0.0977 | 0.4351 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0161 | 0.4497 | 1 |
Trichomonas vaginalis | alpha-galactosidase/alpha-N-acetylgalactosaminidase, putative | 0.0071 | 0.128 | 0.5 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0059 | 0.083 | 0.138 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0052 | 0.059 | 0.2628 |
Loa Loa (eye worm) | hypothetical protein | 0.0068 | 0.1182 | 0.5263 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.